glp-1 available in canada Health approves Rybelsus, the first oral pill to lower cardiovascular risk adults with Type 2 diabetes. #longevity #GLP1 #diabetes #cardiometabolic #hearthealth #metabolichealth #obesitycare #digitalhealth #biotechnews #healthinnovation Canada greenlights first daily GLP-1
Description
Both medications lower A1ca measure of your average blood glucose over the past two to three months 4 but semaglutide typically produces a steeper drop
Exenatide protects against glucose- and lipid-induced endothelial dysfunction: evidence for direct vasodilation effect of GLP-1 receptor agonists in humans
Your health is worth doing it the right way
doi: 10.1097/WNR.0000000000000548, PMID: [DOI] [PubMed] [Google Scholar] 110.Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, et al
The opportunity is clearbut so is the challenge
